+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type and Route of administration and Country

  • ID: 5231459
  • Report
  • November 2020
  • Region: Europe
  • 90 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Paxvax Inc
  • Prokarium Ltd
  • Sanofi
  • Scandinavian Biopharma
  • MORE
According to a new market research study of “Europe Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Analysis by Vaccine Type and Route Of Administration, Europe typhoid fever vaccines market is projected to reach US$ 145.36 million in 2027 from US$ 74.43 million in 2019. The market is estimated to grow at CAGR of 9.6% from 2020 to 2027. The report highlights trends prevailing in the Europe typhoid fever vaccines market and the factors driving market along with those that act as hindrances.

The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.

Europe typhoid fever vaccines market is expected to grow owing to key factor increase in number of EU citizens travelling outside Europe and presence of major market players in the Europe. However, side effects associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.

Leading companies operating in the Europe typhoid fever vaccines market are Sanofi, GlaxoSmithKline plc, Paxvax Inc, Prokarium Ltd., and Scandinavian Biopharma among others.

Reasons to Buy
  • To understand the Europe typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe typhoid fever vaccines market
  • Efficiently plan M&A and partnership deals in Europe typhoid fever vaccines market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments from Europe typhoid fever vaccines market
  • Obtain market revenue forecast for market by various segments from 2019-2027 in Europe.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Paxvax Inc
  • Prokarium Ltd
  • Sanofi
  • Scandinavian Biopharma
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Typhoid Fever Vaccines Market - by Vaccine Type
1.3.2 Europe Typhoid Fever Vaccines Market - by Route of Administration
1.3.3 Europe Typhoid Fever Vaccines Market - by Country

2. Europe Typhoid Fever Vaccines Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Typhoid Fever Vaccines Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe Typhoid Fever Vaccines Market - Europe PEST Analysis
4.3 Expert Opinion

5. Europe Typhoid Fever Vaccines Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Number of EU Citizens Travelling Outside Europe
5.1.2 Presence of Market Players in the European Region
5.2 Key Restraints
5.2.1 Side Effects Associated with Typhoid Fever Vaccines
5.3 Key Market Opportunities
5.3.1 Growing Pharmaceutical Industry
5.4 Future Trend
5.4.1 Strategic Developments by the Market Players
5.5 Impact Analysis

6. Typhoid Fever Vaccines Market - Europe Analysis
6.1 Europe Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7. Typhoid Fever Vaccines Market - by Vaccine Type
7.1 Overview
7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
7.3 Live Attenuated Vaccine
7.3.1 Overview
7.3.2 Live Attenuated Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Capsular Polysaccharide Vaccines
7.5.1 Overview
7.5.2 Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Conjugate Vaccine
7.6.1 Overview
7.6.2 Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

8. Typhoid Fever Vaccines Market Analysis - by Route of Administration
8.1 Overview
8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
8.2.1 Oral
8.2.1.1 Overview
8.2.2 Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.3 Injectable
8.3.1 Overview
8.3.2 Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

9. Typhoid Fever Vaccines Market Revenue and Forecasts to 2027 - Geographical Analysis
9.1 Europe: Typhoid Fever Vaccines Market
9.1.1 Overview
9.1.2 Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.4 Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.5 Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
9.1.6 Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Germany: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.6.3 Germany: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.7 UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UK: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.7.3 UK: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.8 France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 France: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.8.3 France: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.9 Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.1 Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Spain: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.9.3 Spain: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.10 Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Italy: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.10.3 Italy: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.11 Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Rest of Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.11.3 Rest of Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Company Profiles
11.1 Paxvax Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sanofi
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Prokarium Ltd.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Scandinavian Biopharma
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

List of Tables
Table 1. Europe Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. Germany Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 4. Germany Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 5. UK Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 6. UK Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. France Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 8. France Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 9. Spain Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Spain Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Italy Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Italy Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 13. Rest of Europe Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Rest of Europe Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, Europe Typhoid Fever Vaccines Market

List of Figures
Figure 1. Typhoid Fever Vaccines Market Segmentation
Figure 2. Europe Typhoid Fever Vaccines Market Overview
Figure 3. Capsular Polysaccharide Vaccines Segment Held Largest Share of Typhoid Fever Vaccines Market
Figure 4. Germany Held the Largest Market Share during the Forecast Period
Figure 5. Europe Typhoid Fever Vaccines Market - Leading Country Markets (US$ Mn)
Figure 6. Europe : PEST Analysis
Figure 7. Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Typhoid Fever Vaccines Market - Revenue Forecasts and Analysis-2019-2027
Figure 9. Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
Figure 10. Live Attenuated Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 15. Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Europe: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 18. Europe Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 19. Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
Figure 20. Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 21. UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 22. France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 23. Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 24. Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 25. Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 26. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in European Countries
Note: Product cover images may vary from those shown
  • Sanofi
  • GlaxoSmithKline plc
  • Paxvax Inc
  • Prokarium Ltd
  • Scandinavian Biopharma
Note: Product cover images may vary from those shown
Adroll
adroll